Back
Adaptimmune Therapeutics PLC Stock Price Chart
Elon's New AI Device is About to Shock the World
Click here to see the details because a lot of people could get rich from this new invention.
Sell
22
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.87
Seasonality Move:
-9.46%
7 Day Trial
ALL ACCESS PASS
$
7
Jeff Bezos's Plan Exposed
And for investors who get in now profits could be massive - click here for full story.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.94 | Sell |
| 20-day SMA: | 1 | Sell |
| 50-day SMA: | 1.06 | Sell |
| 200-day SMA: | 0.94 | Sell |
| 8-day EMA: | 0.93 | Sell |
| 20-day EMA: | 0.99 | Sell |
| 50-day EMA: | 1.07 | Sell |
| 200-day EMA: | 1.07 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 33.33 | Sell |
| Chaikin Money Flow: | -562191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.95 - 1.09) | Sell |
| Bollinger Bands (100): | (1.01 - 1.45) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.88 while ADAP 8-day simple moving average is 0.94, which is a Sell signal.
- The stock price of ADAP is 0.88 while Adaptimmune Therapeutics PLC 20-day SMA is 1.00, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 1.06 while ADAP share price is 0.88, making it a Sell technically.
- ADAP stock price is 0.88 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.94, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.88. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
225.05M
Price in USD:
0.88
Share Volume:
754.16K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 0.88 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.88 while ADAP 8-day exponential moving average is 0.93, which is a Sell signal.
- The stock price of ADAP is 0.88 while Adaptimmune Therapeutics PLC 20-day EMA is 0.99, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 1.07 while ADAP share price is 0.88, making it a Sell technically.
- ADAP stock price is 0.88 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.07, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 33.33, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.95 - 1.09), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (1.01 - 1.45), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.